As a consequence of exercise of 530,000 warrants in Vaccibody AS, the share
capital of Vaccibody AS has been increased by NOK 5,300.00 from NOK 2,856,138.45
to NOK 2,861,438.45. The number of outstanding shares in the company is
increased by 530,000 from 285,613,845 to 286,143,845, each with a par value of
Primary insider Agnete B. Fredriksen, President and CSO, has exercised a total
of 330,000 warrants as announced on May 7,2021.
An employee has exercised a total of 200,000 warrants with expiry date of
December 31, 2023. The 200,000 shares have been subscribed for at a strike price
of NOK 12.20 per share.